Merck, Novartis, Hershey, La-Z-Boy: Intellectual Property

The U.S. Federal Trade Commission urged an appeals court to outlaw settlements between brand-drug manufacturers and generic drugmakers on patent expirations, saying they harm competition and hurt consumers.